Best AMR papers of 2025: A Collaboration between AAC and JID for IMARI
Release Date: 02/07/2026
Best AMR papers of 2025: A Collaboration between AAC and JID for IMARI
Editors in Conversation
The Interdisciplinary Meeting of Antimicrobial Resistance and Innovation has launched! The first version of IMARI brought together researchers, clinicians, industry leaders and policymakers to address one of the greatest challenges in modern medicine: antimicrobial resistance” Check the highlights at IMARI.org and prepare for IMARI 2017 from January 27-29, 2027! The inaugural amazing conference took place in Las Vegas. This is the forst time that ASM and IDSA collaborate together in a scientific meeting. One of the sessions involved an unprecedent collaboration between two journals AAC and...
info_outline
Green Labs
Editors in Conversation
Climate change is one of the most pressing issues facing humanity – and is not a future problem. Changes to the Earth’s climate driven by emission of greenhouse gases have led to glaciers shrinking, plant and animal geographic ranges shifting and historical droughts, wildfires and rainfall. What does all of this have to do with the clinical laboratory? Subscribe to Editors in Conversation on , , , or and never miss an episode. Guests: , Director of Clinical Chemistry and Associate Professor at VUMC , bioMérieux Links: : an ASM Laboratory Practices Subcommittee...
info_outline
Rising Antimicrobial Resistance in The Microbial Universe
Editors in Conversation
This is a special live recording of Editors in Conversation at the 2025 ASM Global Research Symposium in Bengaluru, India. We explore the evolving landscape of drug-resistant pathogens—from the intracellular survival strategies of Salmonella to the global rise of multidrug-resistant fungi like Candida auris. This conversation highlights the urgent need for integrated, One Health solutions to combat AMR across human, animal, and environmental domains. Watch this episode: https://youtu.be/G1KtS6MSjHs Topics discussed: The implications of the OneHealth approach for microbiology and...
info_outline
Favorite Clinical Microbiology Papers of 2025
Editors in Conversation
I almost can’t believe that we are wrapping up yet another year on the podcast this month, which has been going strong for 6 years now! And it has been another exciting year in the world of Clin Micro as well with improvements and new assays available for some of our bread and butter tests, but the year also brought about significant developments in the application of AI and digital imaging, use of NGS methods, and probably some cool AST stuff in there too among other things, with many of these advancements published in JCM. And so, as has become customary for the last 6 years, for this...
info_outline
Clinical Trials With the Potential To Change the Management of Prosthetic Joint Infections
Editors in Conversation
Prosthetic joint infections (PJI) remain among the most devastating complications in orthopedic surgery, with increasing incidence paralleling the growth in arthroplasty procedures worldwide. While treatment protocols are well-established, evidence supporting current approaches is lacking, and outcomes remain suboptimal, highlighting the need for improved therapeutic strategies. AAC recently published a minireview of randomized controlled trials and emerging evidence for the management for these difficult to treat infection. Today, we discuss with one of the authors of the manuscript and an ID...
info_outline
Metabolomics
Editors in Conversation
It’s that time of year, folks! No, not leaf-peeping season, or pumpkin spice season or even apple picking season – I’m talking respiratory virus season! The symphony of sniffles and coughs is just around the corner! It’s the time of year that clinical laboratories are stocking up on supplies, developing testing algorithms and putting out communications to try to convince people that every kid with the sniffles does not, in fact, warrant a highly-multiplexed respiratory virus panel test. The diagnostic landscape for respiratory viruses has evolved dramatically in the last five years,...
info_outline
The First OTC Syphilis Test: Clinical Performance and Impact
Editors in Conversation
Treponema pallidum, the causative agent of syphilis, has been around for what seems like forever, causing major outbreaks throughout the millennia and continuing to spread at high rates, globally, into today. When it comes to diagnostic testing, some tests like RPR and VDRL have stood the test of time, having been implemented in the late 1930s and 1940s, and are now used in combination with contemporary methods like EIAs and chemiluminescent assays as the reference standard method to diagnosis syphilis cases. New approaches to screening and diagnosis are needed, however, to increase test...
info_outline
Artificial Intelligence in the Microbiology Laboratory (JCM ed.)
Editors in Conversation
The launch of ChatGPT three years ago brought the concept of artificial intelligence into the daily conversation. Today, it seems all industries, including lab medicine, are integrating AI with the promise of making our lives easier. How do we best navigate implementing this technology into clinical microbiology? How will it be regulated? … and, what is AI anyway? Watch this epsiode: Guests: Dr. Susan Sharp Dr. Kendall Bryant Links: Proceedings of the Clinical Microbiology Open 2024: techniques versus standard microscopy in a reference laboratory in clinical bacteriology This...
info_outline
What Makes a Great Mini-review? (JCM ed.)
Editors in Conversation
The Journal of Clinical Microbiology has a great tradition of publishing mini-reviews on topics that are important to the clinical microbiology community. Minireviews provide “up to the minute” updates on topics pertinent to clinical microbiologists and serve as fabulous training tools for medical professionals, trainees, and researchers across all disciplines. Dr. Humphries and Dr. Ledeboer discuss what makes a great mini-review, and their favorite mini-reviews published in JCM. Watch this episode: https://youtu.be/sXOrfTkoDGM This episode of Editors in Conversation is brought to you by...
info_outline
Emerging Technologies for Rapid Phenotypic AST of Clinical Isolates of Bacteria (JCM ed.)
Editors in Conversation
Antimicrobial resistance is one of the largest threats to global public health, compromising all other advances in modern medicine. At the forefront of detecting AMR is the clinical laboratory. However, walk into any clinical microbiology laboratory today and you will find this important task being accomplished using techniques that barely evolved from the methods proposed by Alexander Fleming, nearly 100 years ago. Bacteria are exposed to antimicrobials, in an in vitro culture system, and growth inhibition is measured after overnight incubation. In the time of laboratory...
info_outlineThe Interdisciplinary Meeting of Antimicrobial Resistance and Innovation has launched! The first version of IMARI brought together researchers, clinicians, industry leaders and policymakers to address one of the greatest challenges in modern medicine: antimicrobial resistance” Check the highlights at IMARI.org and prepare for IMARI 2017 from January 27-29, 2027!
The inaugural amazing conference took place in Las Vegas. This is the forst time that ASM and IDSA collaborate together in a scientific meeting. One of the sessions involved an unprecedent collaboration between two journals AAC and JID published by each society. To celebrate this achievement we had a session of the best AMR papers of 2025 for AAC and JID. This session will be presented here as apart of our series.
Watch this episode: https://youtu.be/XRYl7863z34
Objectives:
- Review the best papers and topics of AMR in 2025 form AAC and JID.
- Discuss the context of each finding and contributions to the AMR community
- Elaborate on the implications for AMR, novelties and how the field is advancing.
Guests:
- Ayesha Khan, Ph.D. Assistant Professor, Pathology & Laboratory Medicine and Associate Director, Division of Clinical Microbiology Biomedical & Translational Research Track. Principal Investigator, UC3P UCI Prime Pre-Health Pathways Program.
- Madison Stellfox, M.D. Ph.D. Assistant Professor of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.
This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at https://asm.org/aac.
If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit https://asm.org/joinasm to sign up.
Visit https://asm.org/aac to browse issues and/or submit a manuscript.
Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates.